welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Cancer Prevention Pharmaceuticals in Collaboration with the NCI and Vanderbilt University Medical Center Initiates Phase 2 Trial to Evaluate CPP-1X in Patients with High Risk of Gastric Cancer
Cancer Prevention Pharmaceuticals, Inc. (“CPP”) announced today the launch of a Phase 2 clinical trial at Vanderbilt University Medical Center to evaluate CPP-1X in patients with precancerous gastric lesions who are at high risk for gastric cancer.
The trial is funded by the National Cancer Institute (NCI) and run in collaboration with Keith T. Wilson, M.D., and Douglas R. Morgan, M.D., MPH, of Vanderbilt University School of Medicine, Vanderbilt University Medical Center, and the Vanderbilt-Ingram Cancer Center.

expertly curated content related to this topic
-
Laparoscopic Total Colectomy and Proctocolectomy for the Treatment of Familial Adenomatous PolyposisOBJECTIVE : To evaluate the safety, feas...
-
Familial Risk-Colorectal Cancer: ESMO Clinical Practice GuidelinesLynch syndrome is the most common heredi...
-
Dietary Polyamine Intake and Risk of Colorectal Adenomatous PolypsBACKGROUND : Putrescine, spermidine, and...
-
#jpouchFAP hashtag for the community...
-
SCALEing F.A.P.: Impact of J-Pouch Surgeries on My Weighthttps://www.youtube.com/watch?v=Nz2p-KzD...
-
Frank A. Sinicrope, MDInterests: Colorectal cancer prevention...
-
Stages and Evaluation of Surgical Innovation: A Clinical Example of the Ileo Neo Rectal Anastomosis After Ulcerative...AIM: So far, not many clinical examples...